To view the PDF file, sign up for a MySharenet subscription.

JSE LIMITED - Index Change Advice - 20141124 Ascendis Health Ltd Shares In Issue Update

Release Date: 14/11/2014 17:20
Code(s): JSER     PDF:  
Wrap Text
Index Change Advice - 20141124 Ascendis Health Ltd Shares In Issue Update

               Ascendis Health Ltd (South Africa): Shares in Issue Change
                             FTSE/JSE Africa Index Series

                                                                      14 November 2014
Following the receipt of updated shares in issue information for Ascendis Health Ltd (South Africa,
constituent) and notification from the Stock Exchange, FTSE and the JSE announces the following
changes:


                                                                                                              Effective From
                         Index                                                    Change
                                                                                                             Start of Trading
FTSE/JSE Small Cap (J202)                                         Ascendis Health Ltd (South Africa,       24 November 2014
                                                                  ZAE000185005, BGLP8C3) will remain in
                                                                  the index with an increased shares in
                                                                  issue total of 266,592,351 and an
                                                                  unchanged investability weighting of
                                                                  42%.


FTSE/JSE All Share (J203)                                         Ascendis Health Ltd will remain in the   24 November 2014
                                                                  index as detailed above.


FTSE/JSE RAFI All Share Index                                     Ascendis Health Ltd will remain in the   24 November 2014
(J263)                                                            index as detailed above.


FTSE/JSE RAFI All Share Capped                                    Ascendis Health Ltd will remain in the   24 November 2014
Index (J283)                                                      index as detailed above.


FTSE/JSE Capped All Share (J303)                                  Ascendis Health Ltd will remain in the   24 November 2014
                                                                  index as detailed above.


FTSE/JSE Style (J330 and J331)                                    Ascendis Health Ltd will remain in the   24 November 2014
                                                                  index as detailed above.


FTSE/JSE All Share Shariah (J143)                                 Ascendis Health Ltd will remain in the   24 November 2014
                                                                  index as detailed above.


FTSE/JSE Shareholder Weighted All                                 Ascendis Health Ltd will remain in the   24 November 2014
Share (J403)                                                      index as detailed above.




For further information or general enquiries please contact us at info@ftse.com or indices@jse.co.za or call:

Client Services in UK:                             Tel: +44 (0) 20 7866 1810
Client Services in Europe, Middle East & Africa:   Tel: +44 (0) 20 7866 1810
 Client Services in US:             New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139
 Client Services in Asia Pacific:   Hong Kong: + 852 2164 3333 Australia:(Domestic Toll-Free) + 1800 653 680 / (International) + 61 (2) 9293 2864 Japan + 81 (3) 3581 2764
 JSE Limited:                       Tel: +27 11 520 7137




Alternatively please visit our website at www.ftse.com or www.ftsejse.co.za

                                                Terms of Use | Copyright © FTSE

Date: 14/11/2014 05:20:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story